Abstract
Abstract
Background
Patients with iron deficiency anemia are treated with iron preparations, but gastrointestinal symptoms such as nausea and vomiting occur frequently. These symptoms may negatively affect the quality of life and work productivity in patients with iron deficiency anemia. This study assessed the impact of nausea and vomiting on the quality of life and work productivity of patients taking iron preparations for heavy menstrual bleeding or anemia.
Methods
An online survey was conducted among patients taking iron preparations for heavy menstrual bleeding or anemia. Demographic data and information about medication use and the health condition were collected. The patients were asked to answer the 5-level EQ-5D version, and work productivity and activity impairment questionnaires. The outcomes were reported by patients in the presences of nausea, vomiting, and nausea or vomiting. The association with the 5-level EQ-5D version utility score for the severity and frequency of the symptoms were also assessed.
Results
A total of 385 patients were enrolled, and 96 were patients with nausea or vomiting, of which 94 were with nausea and 27 were with vomiting. The 5-level EQ-5D version utility scores for the patients with nausea, vomiting, and nausea or vomiting were significantly lower than those of the patients without these symptoms (p < 0.001 for each). The 5-level EQ-5D version utility score was correlated with the severity of nausea and the frequency of vomiting per day (p < 0.001 for each). As for the work productivity and activity impairment, the presenteeism, the overall work impairment, and the activity impairment of the patients with nausea, vomiting, and nausea or vomiting were significantly higher than those without these symptoms (p < 0.001 for each). The absenteeism was slightly higher trend was observed, but not significant.
Conclusion
Patients taking iron preparations who have nausea or vomiting experience a significant burden in terms of poorer quality of life and higher work productivity impairment.
Trial registration
UMIN000045700 (http://www.umin.ac.jp/ctr/). Registered on October 11, 2021.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. World Health Organization. Anaemia in women and children. https://www.who.int/data/gho/data/themes/topics/anaemia_in_women_and_children. Accessed 13 Sept 2023.
2. Ministry of Health, Labour and Welfare. National Health and Nutrition Survey, 2018. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/h30-houkoku_00001.html. Accessed 13 Sept 2023.
3. World Health Organization. Global nutrition targets 2025: anaemia policy brief. https://www.who.int/publications/i/item/WHO-NMH-NHD-14.4. Accessed 13 Sept 2023.
4. Clark SF. Iron deficiency anemia. Nutr Clin Pract. 2008;23(2):128–41.
5. World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. https://www.who.int/publications/i/item/9789240000124. Accessed 13 Sept 2023.